Analysis on the World's HLA Typing Market, 2020-2025 - Rising Adoption of Cross-Matching & Chimerism Testing, Increasing Public Awareness About Transplantations
DUBLIN, March 18, 2020 /PRNewswire/ -- The "HLA Typing Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent), Application (Cancer Research, Infectious & Non Infectious Diseases, Transfusion Therapy), End User (Hospital, Academia and Research) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global HLA typing market is valued at USD 1.2 billion in 2019 and expected to reach USD 1.7 billion by 2025, at a CAGR of 5.9% from 2019 to 2025.
The major players operating in the HLA typing market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Immucor, Inc. (US), CareDx (US), Becton, Dickinson and Company (US), and Hologic (US).
The HLA typing market is projected to grow at a CAGR of 5.9% during the forecast period.
Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research.
Reagents & consumables accounted for the largest market share in 2019.
Based on product and service, the HLA typing market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the HLA typing market in 2019. This can be attributed to the growing application horizons of molecular assay techniques in HLA typing, increasing patient emphasis on effective and early patient profiling during organ transplantation, the growing adoption of molecular diagnostic techniques in research studies, and the rising number of target procedures across major markets.
The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019.
On the basis of technology, the HLA typing market is segmented into molecular and non-molecular assay technologies. The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019. The growth of this segment is attributed to their benefits over non-molecular assays, such as low turnaround times, high procedural efficacy, multi-sample study capabilities, and real-time sample analysis.
The diagnostic applications segment accounted for the largest share of the HLA typing market in 2019.
Based on application, the HLA typing market is segmented into diagnostic and research applications. The diagnostic applications segment dominates the HLA typing market. This is attributed to technological advancements in molecular assay techniques, the increasing adoption of molecular assay procedures for pathogen encounter detection and histocompatibility cross-matching, and the growing incidence of chronic and infectious diseases.
The commercial service providers segment accounted for the largest share of the HLA typing market in 2019.
The HLA typing market, by end user, is segmented into commercial service providers, hospitals & surgical centers, and research laboratories & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the HLA typing market due to the ongoing rapid modernization and adoption of automation in HLA typing, growing outsourcing of R&D activities to said providers, and the increasing consolidation of diagnostic laboratories.
North America accounted for the largest share of the global HLA typing market in 2019.
The HLA typing market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global HLA typing market in 2019. This is majorly attributed to the high adoption of advanced diagnostic technologies, increasing prevalence of target diseases in the US and Canada, and technological advancements. The rising geriatric population and growing funding and support for research are other major factors driving the growth of this regional segment.
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 HLA Typing Market: Market Overview
4.2 Global Market Breakdown, By Product & Service
4.3 Market, By Technology
4.4 Market, By Application
4.5 Market, By End-user
4.6 Geographic Snapshot of the HLA Typing Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Organ Transplantation Procedures
5.2.1.2 Technological Advancements in the Field of HLA Typing
5.2.1.3 Increasing Public-Private Funding for Research
5.2.1.4 Increasing Prevalence of Infectious & Non-Infectious Diseases
5.2.2 Restraints
5.2.2.1 High Cost of HLA Typing Products
5.2.2.2 Limited Reimbursements for Target Procedures
5.2.3 Opportunities
5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing
5.2.3.2 Increasing Public Awareness About Transplantation
5.2.4 Challenges
5.2.4.1 Supply-Demand Gap Between the Number of Organ Donors and Organs Required Annually
5.2.4.2 Dearth of Skilled Professionals for Performing HLA Typing
6 HLA Typing Market, By Product & Service
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Expanding Applications of Molecular Assay Techniques Like PCR and NGS in HLA Typing Will Aid Market Growth
6.3 Instruments
6.3.1 Technological Advancements and Increasing Awareness Support the Adoption of Instruments
6.4 Software & Services
6.4.1 Automation and Digitization in Lab Procedures and Rising Demand for Specialized Equipment are Driving Market Growth
7 HLA Typing Market, By Technology
7.1 Introduction
7.2 Molecular Assay Technologies
7.2.1 PCR-Based Molecular Assays
7.2.1.1 Sequence-Specific Primer-PCR
7.2.1.1.1 Expanding Distribution Networks of Key PCR Manufacturers to Support Market Growth
7.2.1.2 Sequence-Specific Oligonucleotide-PCR
7.2.1.2.1 High Demand of Sso-PCR is Due to Its Benefits in Donor-Recipient Cross-Matching and Disease Diagnosis
7.2.1.3 Real-Time PCR
7.2.1.3.1 Growing End-User Preference for Genome-Based Molecular Diagnostics has Supported the Demand for Real-Time PCR
7.2.1.4 Other PCR-Based Molecular Assays
7.2.2 Sequencing-Based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.1.1 Rising End-User Preference for Low-Cost and Efficient Dna Sequencing Technology Drives Market Growth
7.2.2.2 Next-Generation Sequencing
7.2.2.2.1 High Scalability, Low Turnaround Time, and High-Throughput Capabilities have Fueled the Use of NGS
7.2.2.3 Other Sequencing-Based Molecular Assays
7.3 Non-Molecular Assay Technologies
7.3.1 Rapid Adoption of Molecular Assay Techniques Will Hamper Market Growth in This Segment
8 HLA Typing Market, By Application
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Donor-Recipient Cross-Matching
8.2.1.1 Need for Histocompatibility Cross-Matching in Organ Transplantation Drives Market Growth
8.2.2 Infectious Disease Testing
8.2.2.1 Growing Burden of Infectious Diseases is Likely to Aid Market Growth
8.2.3 Cancer Diagnosis & Prevention
8.2.3.1 Clinical Evidence for the Success of HLA Typing in Cancer Diagnostics Will Positively Affect This Market
8.2.4 Transfusion Therapy
8.2.4.1 Increasing Evidence for the Success of HLA Typing in Blood Transfusion is A Key Contributor to Market Growth
8.2.5 Other Diagnostic Applications
8.3 Research Applications
8.3.1 Rising Funding for Research and Expanding Applications of HLA Typing are Driving Market Growth
9 HLA Typing Market, By End-user
9.1 Introduction
9.2 Commercial Service Providers
9.2.1 Rapid Modernization and Automation in HLA Typing to Support Market Growth in This Segment
9.3 Hospitals & Transplant Centers
9.3.1 High Purchasing Power of Hospitals has Ensured Strong Adoption of Instruments, Reagents, and Consumables
9.4 Research Laboratories & Academic Institutes
9.4.1 Rising Government Support for Research Related to Cancer Diagnosis Will Propel Market Growth
10 HLA Typing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Technological Advancements in the Field of HLA Typing Will Drive Market Growth in the US
10.2.2 Canada
10.2.2.1 Rising Incidence of Cancer Will Support the Adoption of Genomic Research in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Accounted for the Largest Share of the European Market
10.3.2 UK
10.3.2.1 Rising Prevalence of Autoimmune Diseases Drives Market Growth in the UK
10.3.3 France
10.3.3.1 Increasing Organ Rejection Rate Drives the Need for HLA Typing in France
10.3.4 Italy
10.3.4.1 Italy's Healthcare Sector has Witnessed Sluggish Growth in Recent Years
10.3.5 Spain
10.3.5.1 Rising Number of Solid-Organ Transplantation Procedures to Drive Market Growth in Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Supportive Government Regulations Will Drive Market Growth in China
10.4.2 India
10.4.2.1 Increasing Number of Transplantation Procedures Drives Market Growth in India
10.4.3 Japan
10.4.3.1 Limited Research and Exploration in the Diagnostics Field to Limit the Adoption of HLA Procedures
10.4.4 Australia
10.4.4.1 Rising Prevalence of Coeliac Disease in Australia to Support the HLA Typing Market
10.4.5 South Korea
10.4.5.1 Expansion By Leading Market Players in South Korea Will Support Market Growth
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 Brazil Dominates the Latam Market
10.5.2 Mexico
10.5.2.1 Rising Medical Tourism to Support Market Growth in Mexico
10.5.3 Rest of Latam
10.6 Middle East and Africa
10.6.1 MEA Will Hold A Smaller Share and Grow at A Lesser Rate Than Major Regional Markets
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Key Product Launches and Approvals
11.3.2 Key Agreements and Collaborations
11.3.3 Key Acquisitions
11.3.4 Key Expansions
11.4 Competitive Leadership Mapping
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies
12 Company Profiles
(Business Overview, Products and Services Offered, Recent Developments, SWOT Analysis)
12.1 Thermo Fisher Scientific
12.2 Qiagen
12.3 Illumina
12.4 F. Hoffman-La Roche Limited
12.5 Bio-Rad Laboratories
12.6 Becton, Dickinson and Company
12.7 TBG Diagnostics
12.8 Fujirebio
12.9 Takara Bio
12.10 Caredx
12.11 Omixon
12.12 Immucor
12.13 Genome Diagnostics
12.14 Biofortuna
12.15 Creative Biolabs
12.16 Other Companies
12.16.1 Bag Healthcare
12.16.2 Histogenetics
12.16.3 Pacific Biosciences of California
12.16.4 BGI Genomics
12.16.5 Krishgen Biosystems
For more information about this report visit https://www.researchandmarkets.com/r/r5gsn3
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article